| scholarly article | Q13442814 |
| P50 | author | Xiaoyuan Chen | Q67123714 |
| Kai Chen | Q84540047 | ||
| P2093 | author name string | Weibo Cai | |
| Zi-Bo Li | |||
| Lina He | |||
| Qizhen Cao | |||
| Zhanhong Wu | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1162-1171 | |
| P577 | publication date | 2007-06-15 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression | |
| P478 | volume | 48 |
| Q38949851 | (18) F labeled RGD-A7R peptide for dual integrin and VEGF-targeted tumor imaging in mice bearing U87MG tumors |
| Q33956262 | (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer |
| Q34028144 | (44)Sc: an attractive isotope for peptide-based PET imaging. |
| Q36311285 | (64)Cu-NODAGA-c(RGDyK) Is a Promising New Angiogenesis PET Tracer: Correlation between Tumor Uptake and Integrin α(V)β(3) Expression in Human Neuroendocrine Tumor Xenografts |
| Q39861931 | (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging |
| Q39892388 | (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging |
| Q40023168 | (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression |
| Q38111973 | (89)Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges. |
| Q36743097 | 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging |
| Q30497615 | 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression |
| Q39853361 | 64Cu-labeled PEGylated polyethylenimine for cell trafficking and tumor imaging |
| Q37172093 | A practical guide to the construction of radiometallated bioconjugates for positron emission tomography. |
| Q37924161 | Animal tumor models for PET in drug development |
| Q37558860 | Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar |
| Q48134659 | Biodistribution of the ¹⁸F-FPPRGD₂ PET radiopharmaceutical in cancer patients: an atlas of SUV measurements |
| Q37668316 | Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents |
| Q34565032 | Chimeric ferritin nanocages for multiple function loading and multimodal imaging |
| Q26771417 | Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 |
| Q34812125 | Clustered Arg-Gly-Asp peptides enhances tumor targeting of nonviral vectors |
| Q33870879 | Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease |
| Q37126530 | Copper-64 Radiopharmaceuticals for Oncologic Imaging |
| Q37478003 | Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research |
| Q38217835 | Current molecular imaging positron emitting radiotracers in oncology |
| Q34162650 | Cyclic RGD Peptides Incorporating Cycloalkanes: Synthesis and Evaluation as PET Radiotracers for Tumor Imaging |
| Q37593608 | Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models |
| Q60930279 | Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics |
| Q47362426 | Dendrimer-based contrast agents for PET imaging |
| Q64072350 | Design of an Amphiphilic Poly(aspartamide)-mediated Self-assembled Nanoconstruct for Long-Term Tumor Targeting and Bioimaging |
| Q46321334 | Development of multi-functional chelators based on sarcophagine cages. |
| Q33686825 | Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect. |
| Q30524330 | Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe |
| Q39652458 | Dynamic visualization of RGD-quantum dot binding to tumor neovasculature and extravasation in multiple living mouse models using intravital microscopy. |
| Q42333752 | Editorial European Journal of Nuclear Medicine and Molecular Imaging |
| Q55130405 | Effect of multiple cyclic RGD peptides on tumor accumulation and intratumoral distribution of IRDye 700DX-conjugated polymers. |
| Q37724879 | Engineered cystine-knot miniproteins for diagnostic applications |
| Q33708506 | Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects |
| Q37648915 | Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68. |
| Q33832487 | Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature |
| Q39674540 | Evaluation of Copper-64 Labeled AmBaSar Conjugated Cyclic RGD Peptide for Improved MicroPET Imaging of Integrin αvβ3 Expression |
| Q51732415 | Evaluation of a dimeric-cRGD peptide for targeted PET-CT imaging of peripheral angiogenesis in diabetic mice. |
| Q36113183 | Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃. |
| Q36742890 | First experience with clinical-grade ([18F]FPP(RGD₂): an automated multi-step radiosynthesis for clinical PET studies |
| Q33833584 | Functional mutation of multiple solvent-exposed loops in the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein |
| Q36777305 | HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging |
| Q35999557 | Imaging key biomarkers of tumor angiogenesis |
| Q37917591 | Imaging of Induced Pluripotent Stem Cells: From Cellular Reprogramming to Transplantation. |
| Q37019430 | Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64 |
| Q27008410 | Imaging: guiding the clinical translation of cardiac stem cell therapy |
| Q34196969 | Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides |
| Q39804673 | Imparting multivalency to a bifunctional chelator: a scaffold design for targeted PET imaging probes |
| Q41157466 | Interface Immobilization Chemistry of cRGD-based Peptides Regulates Integrin Mediated Cell Adhesion |
| Q36649655 | Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis |
| Q37014205 | Labeling peptides with PET radiometals: Vulcan's forge. |
| Q36663342 | Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging |
| Q34995512 | Macrocyclic chelator assembled RGD multimers for tumor targeting |
| Q37193000 | Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides |
| Q34496670 | Molecular imaging in cancer treatment |
| Q37424334 | Molecular imaging targeting peptide receptors |
| Q39657710 | Multimerization of cRGD Peptides by Click Chemistry: Synthetic Strategies, Chemical Limitations, and Influence on Biological Properties |
| Q57757444 | Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression |
| Q35572430 | Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. |
| Q38369824 | Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency |
| Q39506968 | Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA. |
| Q38675919 | NMR Insights into the Structure-Function Relationships in the Binding of Melanocortin Analogues to the MC1R Receptor |
| Q35234726 | Nanotherapeutics in angiogenesis: synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryos |
| Q30528528 | Near-infrared-labeled peptide multimer functions as phage mimic for high affinity, specific targeting of colonic adenomas in vivo (with videos). |
| Q35085201 | Neuroimaging of epilepsy: lesions, networks, oscillations. |
| Q33836004 | Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation |
| Q39868638 | Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib |
| Q46083932 | Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers |
| Q40044646 | Novel near-infrared fluorescent integrin-targeted DFO analogue |
| Q36533804 | One-step and one-pot-two-step radiosynthesis of cyclo-RGD-(18)F-aryltrifluoroborate conjugates for functional imaging. |
| Q34435482 | One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging |
| Q36777406 | Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers |
| Q37366243 | PET Imaging of Angiogenesis |
| Q33728010 | PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using (64)Cu-Labeled Monoclonal Antibody 61B |
| Q42726009 | PET Imaging of Integrin αVβ3 Expression |
| Q34677001 | PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide |
| Q27004457 | PET probes beyond (18)F-FDG |
| Q36746620 | Peptide heterodimers for molecular imaging |
| Q33846924 | Peptides and peptide hormones for molecular imaging and disease diagnosis |
| Q35062113 | Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels |
| Q39114901 | Polyaspartic acid coated iron oxide nanoprobes for PET/MRI imaging. |
| Q36777285 | Positron emission tomography tracers for imaging angiogenesis |
| Q30475818 | Preclinical molecular imaging of tumor angiogenesis. |
| Q59465727 | Preclinical validations of [F]FPyPEGCBT-(RGDfK): a F-labelled RGD peptide prepared by ligation of 2-cyanobenzothiazole and 1,2-aminothiol to image angiogenesis |
| Q88656687 | Preparation and preclinical evaluation of a 68Ga-labelled c(RGDfK) conjugate comprising the bifunctional chelator NODIA-Me |
| Q30714285 | Progress on the diagnosis and evaluation of brain tumors. |
| Q30364628 | Quantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging. |
| Q36107186 | Quantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model |
| Q34044872 | RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo |
| Q38166986 | RGD-based PET tracers for imaging receptor integrin αv β3 expression |
| Q38897848 | RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells |
| Q28242926 | RGD-human serum albumin conjugates as efficient tumor targeting probes |
| Q34912643 | Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT |
| Q88849351 | Radiolabeled Dendrimers for Nuclear Medicine Applications |
| Q37480688 | Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency |
| Q38755295 | Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? |
| Q37990409 | Radiolabelled RGD peptides for imaging and therapy |
| Q37847064 | Radiometallated peptides for molecular imaging and targeted therapy. |
| Q37990399 | Radiopharmaceutical development of radiolabelled peptides |
| Q42873376 | Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. |
| Q37515337 | Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods |
| Q39768994 | Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery. |
| Q26768227 | Small Molecule Radiopharmaceuticals - A Review of Current Approaches |
| Q33739333 | Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159. |
| Q35999606 | Stroma targeting nuclear imaging and radiopharmaceuticals |
| Q35194685 | Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy |
| Q38762618 | Synthesis and Evaluation of (99m)Tc-Labeled Dimeric Folic Acid for FR-Targeting |
| Q35681062 | Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo |
| Q55157062 | Synthesis and evaluation of ortho-[18F] fluorocelecoxib for COX-2 cholangiocarcinoma imaging. |
| Q55463868 | Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting αvβ3 integrin expression |
| Q41949498 | Synthesis, Chemical Characterization and Multiscale Biological Evaluation of a Dimeric-cRGD Peptide for Targeted Imaging of α V β 3 Integrin Activity |
| Q39151186 | Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals |
| Q37790065 | Target-specific delivery of peptide-based probes for PET imaging |
| Q30395463 | Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging |
| Q38080002 | The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging |
| Q35641927 | Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging |
| Q37714259 | Triazine-based tool box for developing peptidic PET imaging probes: syntheses, microfluidic radiolabeling, and structure-activity evaluation |
| Q33505899 | Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting |
| Q33824812 | Tumor vasculature targeted photodynamic therapy for enhanced delivery of nanoparticles |
| Q39979082 | Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells |
| Q34912582 | Why integrin as a primary target for imaging and therapy |
| Q39979513 | alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide. |
Search more.